These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 34374028)
1. The Effect of Treatment Discontinuation During the COVID-19 Pandemic on Visual Acuity in Exudative Neovascular Age-Related Macular Degeneration: 1-Year Results. Stattin M; Ahmed D; Graf A; Haas AM; Kickinger S; Jacob M; Krepler K; Ansari-Shahrezaei S Ophthalmol Ther; 2021 Dec; 10(4):935-945. PubMed ID: 34374028 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a calculation model to estimate the impact of the COVID-19 pandemic lockdown on visual acuity in neovascular AMD. Stattin M; Haas AM; Ahmed D; Graf A; Krepler K; Ansari-Shahrezaei S Eur J Ophthalmol; 2022 Jul; 32(4):2312-2318. PubMed ID: 34726553 [TBL] [Abstract][Full Text] [Related]
3. Results of the treatment of patients with exudative AMD during the COVID-19 pandemic. Arruabarrena C; Montejano-Milner R; de Aragón F; Allendes G; Teus MA Arch Soc Esp Oftalmol (Engl Ed); 2022 Apr; 97(4):184-190. PubMed ID: 35523464 [TBL] [Abstract][Full Text] [Related]
4. Long-term impact of delayed follow-up due to COVID-19 lockdown on patients with neovascular age-related macular degeneration. Szegedi S; Ebner C; Miháltz K; Wachter T; Vécsei-Marlovits PV BMC Ophthalmol; 2022 May; 22(1):228. PubMed ID: 35596203 [TBL] [Abstract][Full Text] [Related]
5. [Results of the treatment of patients with exudative AMD during the COVID-19 pandemic]. Arruabarrena C; Montejano-Milner R; de Aragón F; Allendes G; Teus MA Arch Soc Esp Oftalmol; 2022 Apr; 97(4):184-190. PubMed ID: 34876774 [TBL] [Abstract][Full Text] [Related]
6. Impact on Visual Acuity in Neovascular Age Related Macular Degeneration (nAMD) in Europe Due to COVID-19 Pandemic Lockdown. Arruabarrena C; Toro MD; Onen M; Malyugin BE; Rejdak R; Tognetto D; Zweifel S; Giglio R; Teus MA J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362066 [TBL] [Abstract][Full Text] [Related]
7. The effect of COVID-19 pandemic restrictions on neovascular AMD patients treated with treat-and-extend protocol. Sevik MO; Aykut A; Özkan G; Dericioğlu V; Şahin Ö Int Ophthalmol; 2021 Sep; 41(9):2951-2961. PubMed ID: 33864577 [TBL] [Abstract][Full Text] [Related]
8. Seven-Year Visual and Anatomical Outcomes of Intravitreal Vascular Endothelial Growth Factor Inhibition for Neovascular Age-Related Macular Degeneration. Stattin M; Forster J; Ahmed D; Haas AM; Graf A; Krepler K; Ansari-Shahrezaei S J Ophthalmol; 2020; 2020():8345850. PubMed ID: 32211201 [TBL] [Abstract][Full Text] [Related]
9. Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies. Carrasco J; Pietsch GA; Nicolas MP; Koerber C; Bennison C; Yoon J Adv Ther; 2020 Jan; 37(1):300-315. PubMed ID: 31728825 [TBL] [Abstract][Full Text] [Related]
10. Defining response to anti-VEGF therapies in neovascular AMD. Amoaku WM; Chakravarthy U; Gale R; Gavin M; Ghanchi F; Gibson J; Harding S; Johnston RL; Kelly SP; Lotery A; Mahmood S; Menon G; Sivaprasad S; Talks J; Tufail A; Yang Y Eye (Lond); 2015 Jun; 29(6):721-31. PubMed ID: 25882328 [TBL] [Abstract][Full Text] [Related]
11. [Impact of the French 2020 COVID-19 lockdown on the treatment and follow-up of patients with exudative age-related macular degeneration]. Auger A; Khanna RK; Bonicel P; Pisella PJ; Le Lez ML J Fr Ophtalmol; 2023 Jun; 46(6):596-604. PubMed ID: 37248127 [TBL] [Abstract][Full Text] [Related]
12. SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United States. Khanani AM; Skelly A; Bezlyak V; Griner R; Torres LR; Sagkriotis A Ophthalmol Retina; 2020 Feb; 4(2):122-133. PubMed ID: 31812631 [TBL] [Abstract][Full Text] [Related]
13. TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS. Starr MR; Kung FF; Mejia CA; Bui YT; Bakri SJ Retina; 2020 Sep; 40(9):1665-1672. PubMed ID: 31725524 [TBL] [Abstract][Full Text] [Related]
14. Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration. Brynskov T; Munch IC; Larsen TM; Erngaard L; Sørensen TL Acta Ophthalmol; 2020 Mar; 98(2):132-138. PubMed ID: 31282617 [TBL] [Abstract][Full Text] [Related]